Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
Submitted by
admin
on February 3, 2016 - 5:30pm
Source:
Fierce Pharma Marketing
News Tags:
bloodthinners
Bristol-Myers Squibb
Eliquis
Xarelto
Pradaxa
Bayer
Pfizer
JNJ
Boehringer Ingelheim
Headline:
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
Do Not Allow Advertisers to Use My Personal information
